title: Randomized clinical trials in pancreatic adenocarcinoma.
abstract: This article critically reviews and ranks 107 prospective, randomized controlled trials (RCT) for pancreatic adenocarcinoma published between 2000 and 2008 identified through a standard MEDLINE literature search strategy, according to a standardized, previously published 3-tiered system (Ia, Ib, and Ic). All trials included in this article are Ia or Ib. Types of treatment reviewed include surgery, chemotherapy, molecular therapy, radiation therapy, immunotherapy, and palliative therapy.
authors.affiliation: Department of Surgery, Memorial Sloan-Kettering Cancer Center, Hepatopancreaticobiliary Service, C-896, 1275 York Avenue, NY 10021, USA.
authors.forename: Udo
authors.initials: U
authors.lastname: Rudloff
authors.forename: Ajay V
authors.initials: AV
authors.lastname: Maker
authors.forename: Murray F
authors.initials: MF
authors.lastname: Brennan
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Allen
mesh_terms: D000230:Adenocarcinoma / Q000628:therapy*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic